{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:16:29Z","timestamp":1778969789424,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bpg.2014.11.003","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T05:04:05Z","timestamp":1415768645000},"page":"113-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The use of molecular markers in predicting dysplasia and guiding treatment"],"prefix":"10.1016","volume":"29","author":[{"given":"Sebastian","family":"Zeki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2014.11.003_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis","volume":"61","author":"Desai","year":"2012","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2013.07.046","article-title":"Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus","volume":"79","author":"Gordon","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2014.11.003_bib3","series-title":"British society of gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus","first-page":"1","author":"Fitzgerald","year":"2013"},{"issue":"3","key":"10.1016\/j.bpg.2014.11.003_bib4","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association technical review on the management of Barrett's esophagus","volume":"140","author":"Spechler","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2014.11.003_bib5","series-title":"Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study","first-page":"1","author":"Bhat","year":"2014"},{"issue":"12","key":"10.1016\/j.bpg.2014.11.003_bib6","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/gutjnl-2013-306508","article-title":"The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands","volume":"63","author":"Lavery","year":"2014","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bpg.2014.11.003_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2559.2010.03571.x","article-title":"A\u00a0study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase)","volume":"56","author":"Sonwalkar","year":"2010","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.bpg.2014.11.003_bib8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/ajg.2010.171","article-title":"Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated","volume":"105","author":"Curvers","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"10.1016\/j.bpg.2014.11.003_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","article-title":"Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study","volume":"103","author":"Bhat","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.bpg.2014.11.003_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1572-0241.2005.41300.x","article-title":"Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort","volume":"100","author":"Dulai","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2014.11.003_bib11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2011.06.055","article-title":"Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus","volume":"141","author":"Wani","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2014.11.003_bib12","first-page":"1","article-title":"Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel","author":"Duits","year":"2014","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bpg.2014.11.003_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2014.2511","article-title":"Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial","volume":"311","author":"Phoa","year":"2014","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.bpg.2014.11.003_bib14","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","article-title":"Radiofrequency ablation in Barrett's esophagus with dysplasia","volume":"360","author":"Shaheen","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2014.11.003_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.bpg.2014.11.003_bib16","doi-asserted-by":"crossref","first-page":"8990","DOI":"10.1073\/pnas.1100600108","article-title":"Two-phase dynamics of p53 in the DNA damage response","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpg.2014.11.003_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1044-579X(02)00099-8","article-title":"The p53\u2013Mdm2 module and the ubiquitin system","volume":"13","author":"Michael","year":"2003","journal-title":"Cancer Biol Semin"},{"key":"10.1016\/j.bpg.2014.11.003_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10620-006-3093-3","article-title":"TP53 gene mutations are rare in nondysplastic Barrett's esophagus","volume":"51","author":"Novotna","year":"2006","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.bpg.2014.11.003_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","article-title":"Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity","volume":"45","author":"Dulak","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-5223(96)70441-5","article-title":"Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases","volume":"111","author":"Schneider","year":"1996","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.bpg.2014.11.003_bib21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ng.3013","article-title":"Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis","volume":"46","author":"Weaver","year":"2014","journal-title":"Nat Genet"},{"issue":"24","key":"10.1016\/j.bpg.2014.11.003_bib22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/jnci\/91.24.2087","article-title":"Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's tissue)","volume":"91","author":"Galipeau","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.bpg.2014.11.003_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2559.2010.03715.x","article-title":"Novel staining pattern of p53 in Barrett's dysplasia\u2013the absent pattern","volume":"57","author":"Kaye","year":"2010","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.bpg.2014.11.003_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2559.2009.03288.x","article-title":"Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry","volume":"54","author":"Kaye","year":"2009","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.bpg.2014.11.003_bib25","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/ajg.2009.437","article-title":"Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study","volume":"104","author":"Sikkema","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.bpg.2014.11.003_bib26","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1158\/1055-9965.EPI-07-2734","article-title":"Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus","volume":"17","author":"Rygiel","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.bpg.2014.11.003_bib27","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1572-0241.2002.06032.x","article-title":"p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression","volume":"97","author":"Skacel","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2014.11.003_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1572-0241.2001.03851.x","article-title":"p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression","volume":"96","author":"Weston","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.bpg.2014.11.003_bib29","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gut.2005.083295","article-title":"TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort","volume":"55","author":"Murray","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2014.11.003_bib30","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.041","article-title":"Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus","volume":"143","author":"Bird-Lieberman","year":"2012","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2014.11.003_bib31","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2001.05261.x","article-title":"Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables","volume":"96","author":"Rabinovitch","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2014.11.003_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/CBM-2008-4101","article-title":"Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus","volume":"4","author":"Kerkhof","year":"2008","journal-title":"Cancer Biomarkers"},{"issue":"7","key":"10.1016\/j.bpg.2014.11.003_bib33","first-page":"1669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets","volume":"95","author":"Reid","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.bpg.2014.11.003_bib34","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","article-title":"Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression","volume":"96","author":"Reid","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib35","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0040067","article-title":"NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma","volume":"4","author":"Galipeau","year":"2007","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.bpg.2014.11.003_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1055-9965.EPI-05-0246","article-title":"Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation","volume":"15","author":"Wongsurawat","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"10.1016\/j.bpg.2014.11.003_bib37","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1073\/pnas.93.14.7081","article-title":"17p (p53) allelic losses, 4N (G2\/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus","volume":"93","author":"Galipeau","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.bpg.2014.11.003_bib38","first-page":"2292","article-title":"17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy","volume":"54","author":"Blount","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2014.11.003_bib39","first-page":"1873","article-title":"Allele loss of 9p21 and mutation of the CDKN2\/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus","volume":"13","author":"Barrett","year":"1996","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bpg.2014.11.003_bib40","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/cncr.22643","article-title":"Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population","volume":"109","author":"Rygiel","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2353\/jmoldx.2006.050118","article-title":"The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus","volume":"8","author":"Brankley","year":"2006","journal-title":"J\u00a0Mol Diagn"},{"issue":"5","key":"10.1016\/j.bpg.2014.11.003_bib42","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/modpathol.3800088","article-title":"Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens","volume":"17","author":"Fahmy","year":"2004","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2014.11.003_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(12)61675-8","article-title":"Su1181 A diagnostic DNA fish biomarker assay identifies HGD or EAC in Barrett esophagus","volume":"142","author":"Pacha","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bpg.2014.11.003_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1101\/gr.10.8.1126","article-title":"Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays","volume":"10","author":"Mei","year":"2000","journal-title":"Genome Res"},{"issue":"3","key":"10.1016\/j.bpg.2014.11.003_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/CBM-2009-0618","article-title":"Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity","volume":"5","author":"Kissel","year":"2009","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.bpg.2014.11.003_bib46","first-page":"1","article-title":"Deletion at fragile sites is a common and early event in Barrett's esophagus","author":"Lai","year":"2010","journal-title":"Mol Cancer Res"},{"issue":"10","key":"10.1016\/j.bpg.2014.11.003_bib47","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1158\/1078-0432.CCR-08-2494","article-title":"Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma","volume":"15","author":"Paulson","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.bpg.2014.11.003_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1768","article-title":"Genetic clonal diversity predicts progression to esophageal adenocarcinoma","volume":"38","author":"Maley","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.bpg.2014.11.003_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/1940-6207.CAPR-13-0289","article-title":"Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus","volume":"7","author":"Li","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm.2616","article-title":"Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus","volume":"18","author":"Bird-Lieberman","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2004.06.025","article-title":"p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations","volume":"217","author":"Hardie","year":"2005","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.bpg.2014.11.003_bib52","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Eads","year":"2001","journal-title":"Cancer Res AACR"},{"issue":"4","key":"10.1016\/j.bpg.2014.11.003_bib53","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-12-2880","article-title":"DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus","volume":"19","author":"Alvi","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.bpg.2014.11.003_bib54","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.01.019","article-title":"Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma","volume":"144","author":"Wu","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2014.11.003_bib55","first-page":"382","article-title":"Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma","volume":"5","author":"Agarwal","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.bpg.2014.11.003_bib56","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-09-0028","article-title":"Priority report a multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus","volume":"10","author":"Jin","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2014.11.003_bib57","article-title":"Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus","author":"Streppel","year":"2013","journal-title":"Oncogene"},{"issue":"7471","key":"10.1016\/j.bpg.2014.11.003_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bpg.2014.11.003_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.bpg.2014.11.003_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.gastro.2012.10.030","article-title":"Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice","volume":"144","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.bpg.2014.11.003_bib61","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpg.2014.11.003_bib62","doi-asserted-by":"crossref","first-page":"c4372","DOI":"10.1136\/bmj.c4372","article-title":"Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study","volume":"341","author":"Kadri","year":"2010","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.bpg.2014.11.003_bib63","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1055-9965.EPI-06-0492","article-title":"Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis","volume":"15","author":"Chao","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.bpg.2014.11.003_bib64","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1158\/1055-9965.EPI-07-0624","article-title":"Leukocyte telomere length predicts cancer risk in Barrett's esophagus","volume":"16","author":"Risques","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T04:14:02Z","timestamp":1566015242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691814001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1521691814001619"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2014.11.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of molecular markers in predicting dysplasia and guiding treatment","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2014.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}